Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3853)
All Articles published online
|
May 7, 2007 (publication date) through May 6, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Meurs EF, Breiman A. The interferon inducing pathways and the hepatitis C virus. World J Gastroenterol 2007; 13(17): 2446-2454 [PMID: 17552028 DOI: 10.3748/wjg.v13.i17.2446] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i17/2446.htm |
| Number | Citing Articles |
| 1 |
Sophia S. Wang, M. Concepcion Bratti, Ana Cecilia Rodríguez, Rolando Herrero, Robert D. Burk, Carolina Porras, Paula González, Mark E. Sherman, Sholom Wacholder, Z. Elizabeth Lan, Mark Schiffman, Stephen J. Chanock, Allan Hildesheim. Common Variants in Immune and DNA Repair Genes and Risk for Human Papillomavirus Persistence and Progression to Cervical Cancer. Journal of Infectious Diseases 2009; 199(1): 20 doi: 10.1086/595563
|
| 2 |
Zhi Li, Hong Yao, Yan Ma, Qingming Dong, Yangchao Chen, Ying Peng, Bo‐jian Zheng, Jian‐dong Huang, Chu‐yan Chan, Marie C. Lin, Joseph J Sung, Kwok Yun Yuen, Hsiang‐fu Kung, Ming‐Liang He. Inhibition of HBV gene expression and replication by stably expressed interferon‐α1 via adeno‐associated viral vectors. The Journal of Gene Medicine 2008; 10(6): 619 doi: 10.1002/jgm.1174
|
| 3 |
Daniel P Webster, Paul Klenerman, Jane Collier, Katie JM Jeffery. Development of novel treatments for hepatitis C. The Lancet Infectious Diseases 2009; 9(2): 108 doi: 10.1016/S1473-3099(09)70020-9
|
| 4 |
Pasi Kaukinen, Maarit Sillanpää, Laura Nousiainen, Krister Melén, Ilkka Julkunen. Hepatitis C virus NS2 protease inhibits host cell antiviral response by inhibiting IKKε and TBK1 functions. Journal of Medical Virology 2013; 85(1): 71 doi: 10.1002/jmv.23442
|
| 5 |
Kazuaki Inoue, Kyoko Tsukiyama-Kohara, Chiho Matsuda, Mitsutoshi Yoneyama, Takashi Fujita, Shusuke Kuge, Makoto Yoshiba, Michinori Kohara. Impairment of interferon regulatory factor-3 activation by hepatitis C virus core protein basic amino acid region 1. Biochemical and Biophysical Research Communications 2012; 428(4): 494 doi: 10.1016/j.bbrc.2012.10.079
|
| 6 |
Tomoh Matsumiya, Tadaatsu Imaizumi, Hidemi Yoshida, Kei Satoh. Antiviral Signaling Through Retinoic Acid-Inducible Gene-I-Like Receptors. Archivum Immunologiae et Therapiae Experimentalis 2011; 59(1): 41 doi: 10.1007/s00005-010-0107-9
|
| 7 |
Premashis Kar, Deepak Kumar, Phani Kumar Gumma, Soumya Jyoti Chowdhury, Vijay Kumar Karra. Down regulation of TRIF, TLR3, and MAVS in HCV infected liver correlates with the outcome of infection. Journal of Medical Virology 2017; 89(12): 2165 doi: 10.1002/jmv.24849
|
| 8 |
Michael A. Chattergoon, Jordana S. Levine, Rachel Latanich, William O. Osburn, David L. Thomas, Andrea L. Cox. High Plasma Interleukin-18 Levels Mark the Acute Phase of Hepatitis C Virus Infection. The Journal of Infectious Diseases 2011; 204(11): 1730 doi: 10.1093/infdis/jir642
|
| 9 |
Óscar Brochado-Kith, Alicia Gómez Sanz, Luis Miguel Real, Javier Crespo García, Pablo Ryan Murúa, Juan Macías, Joaquín Cabezas González, Jesús Troya, Juan Antonio Pineda, María Teresa Arias Loste, Victorino Díez Viñas, María Ángeles Jiménez-Sousa, Luz María Medrano de Dios, Isabel Cuesta De la Plaza, Sara Monzón Fernández, Salvador Resino García, Amanda Fernández-Rodríguez. MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection. Journal of Clinical Medicine 2019; 8(6): 849 doi: 10.3390/jcm8060849
|
| 10 |
Claire Gondeau, Lydiane Pichard-Garcia, Patrick Maurel. Cellular models for the screening and development of anti-hepatitis C virus agents. Pharmacology & Therapeutics 2009; 124(1): 1 doi: 10.1016/j.pharmthera.2009.05.010
|
| 11 |
Lina Yi, Yaqing He, Ying Chen, Hsiang-Fu Kung, Ming-Liang He. Potent Inhibition of Human Enterovirus 71 Replication by Type I Interferon Subtypes. Antiviral Therapy 2011; 16(1): 51 doi: 10.3851/IMP1720
|
| 12 |
Celia Perales, Nathan M. Beach, Isabel Gallego, Maria Eugenia Soria, Josep Quer, Juan Ignacio Esteban, Charles Rice, Esteban Domingo, Julie Sheldon. Response of Hepatitis C Virus to Long-Term Passage in the Presence of Alpha Interferon: Multiple Mutations and a Common Phenotype. Journal of Virology 2013; 87(13): 7593 doi: 10.1128/JVI.02824-12
|
| 13 |
Dengyuan Zhou, Qiuyan Li, Fan Jia, Luping Zhang, Shengfeng Wan, Yunchuan Li, Yunfeng Song, Huanchun Chen, Shengbo Cao, Jing Ye. The Japanese Encephalitis Virus NS1′ Protein Inhibits Type I IFN Production by Targeting MAVS. The Journal of Immunology 2020; 204(5): 1287 doi: 10.4049/jimmunol.1900946
|
| 14 |
J. M. P. Liefhebber, P. J. Hensbergen, A. M. Deelder, W. J. M. Spaan, H. C. van Leeuwen. Characterization of hepatitis C virus NS3 modifications in the context of replication. Journal of General Virology 2010; 91(4): 1013 doi: 10.1099/vir.0.016881-0
|
| 15 |
Smitha Kota, Virginia Takahashi, Feng Ni, John K. Snyder, A. Donny Strosberg, Gunnar F. Kaufmann. Direct Binding of a Hepatitis C Virus Inhibitor to the Viral Capsid Protein. PLoS ONE 2012; 7(2): e32207 doi: 10.1371/journal.pone.0032207
|
| 16 |
Aurelie Dubois, Catherine François, Veronique Descamps, Carole Fournier, Czeslaw Wychowski, Jean Dubuisson, Sandrine Castelain, Gilles Duverlie. Enhanced anti-HCV activity of interferon alpha 17 subtype. Virology Journal 2009; 6(1) doi: 10.1186/1743-422X-6-70
|
| 17 |
Yi Wang, Li Liu, Xiang-Jin Meng. The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Functions as a Novel Cytosolic Pathogen-Associated Molecular Pattern To Promote Beta Interferon Induction via a Toll-Like-Receptor-Related TRAF3-Independent Mechanism. mBio 2016; 7(1) doi: 10.1128/mBio.01872-15
|
| 18 |
Xiaowen Liu, Yulian Jiao, Xin Wen, Laicheng Wang, Chunyan Ma, Xuejun Gao, Zi-Jiang Chen, Yueran Zhao. Possible association of VISA gene polymorphisms with susceptibility to systemic lupus erythematosus in Chinese population. Molecular Biology Reports 2011; 38(7): 4583 doi: 10.1007/s11033-010-0590-4
|
| 19 |
Mohammed Asmal, Michael Seaman, Wenyu Lin, Raymond T Chung, Norman L Letvin, Ralf Geiben-Lynn. Inhibition of HCV by the serpin antithrombin III. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-226
|
| 20 |
Luyu Yao, Xiaobo Yan, Huijia Dong, David R Nelson, Chen Liu, Xiaoyu Li. Expression of an IRF-3 fusion protein and mouse estrogen receptor, inhibits hepatitis C viral replication in RIG-I-deficient Huh 7.5 cells. Virology Journal 2011; 8(1) doi: 10.1186/1743-422X-8-445
|
| 21 |
Shuvasish Choudhury, Debojyoti Moulick, Anupom Borah, Purbajyoti Saikia, Muhammed Khairujjaman Mazumder. In search of drugs to alleviate suppression of the host's innate immune responses against SARS-CoV-2 using a molecular modeling approach. In Silico Pharmacology 2021; 9(1) doi: 10.1007/s40203-021-00085-y
|
| 22 |
Michael A. Joyce, Karyn M. Berry-Wynne, Theodore dos Santos, William R. Addison, Nicola McFarlane, Tom Hobman, D. Lorne Tyrrell, Glenn Randall. HCV and flaviviruses hijack cellular mechanisms for nuclear STAT2 degradation: Up-regulation of PDLIM2 suppresses the innate immune response. PLOS Pathogens 2019; 15(8): e1007949 doi: 10.1371/journal.ppat.1007949
|
| 23 |
Thomas M. Petro. IFN Regulatory Factor 3 in Health and Disease. The Journal of Immunology 2020; 205(8): 1981 doi: 10.4049/jimmunol.2000462
|
| 24 |
Arthur Donny Strosberg, Smitha Kota, Virginia Takahashi, John K. Snyder, Guillaume Mousseau. Core as a Novel Viral Target for Hepatitis C Drugs. Viruses 2010; 2(8): 1734 doi: 10.3390/v2081734
|
| 25 |
B. Cacopardo, G. Nunnari, L. Nigro. Clearance of HCV RNA following acute hepatitis A superinfection. Digestive and Liver Disease 2009; 41(5): 371 doi: 10.1016/j.dld.2007.11.015
|
| 26 |
Bianhong Zhang, Meng Li, Liang Chen, Kai Yang, Yufei Shan, Lianhui Zhu, Shaogang Sun, Lin Li, Chen Wang. The TAK1-JNK cascade is required for IRF3 function in the innate immune response. Cell Research 2009; 19(4): 412 doi: 10.1038/cr.2009.8
|
| 27 |
Mario U. Mondelli, Stefania Varchetta, Francesco Negro. Liver Immunology. 2014; : 207 doi: 10.1007/978-3-319-02096-9_15
|
| 28 |
Tibebeselassie Seyoum Keflie, Hans Konrad Biesalski. Micronutrients and bioactive substances: Their potential roles in combating COVID-19. Nutrition 2021; 84: 111103 doi: 10.1016/j.nut.2020.111103
|
| 29 |
Doaa I. Hashad, Perihan E. Salem, Dina M. Abdallah. Toll like receptor 3 expression as a novel predictor of response to treatment in chronic hepatitis C virus patients. Scandinavian Journal of Clinical and Laboratory Investigation 2011; 71(8): 641 doi: 10.3109/00365513.2011.624196
|
| 30 |
Scott J. Bergman, McKenzie C. Ferguson, Cathy Santanello. Interferons as Therapeutic Agents for Infectious Diseases. Infectious Disease Clinics of North America 2011; 25(4): 819 doi: 10.1016/j.idc.2011.07.008
|
| 31 |
Zachary P. Guinn, Thomas M. Petro. Interferon regulatory factor 3 plays a role in macrophage responses to interferon-γ. Immunobiology 2019; 224(4): 565 doi: 10.1016/j.imbio.2019.04.004
|
| 32 |
Carlo Ferrari, Valeria Barili, Stefania Varchetta, Mario U. Mondelli. The Liver. 2020; : 821 doi: 10.1002/9781119436812.ch63
|